Company Overview of EPIX Pharmaceuticals, Inc.
Key Executives for EPIX Pharmaceuticals, Inc.
|Elkan R. Gamzu Ph.D.||49 Relationships||Chief Executive Officer, President, and Director||73|
|Ally Cantor||No Relationships||Director of Marketing Team||--|
|Mike Gnojewski||No Relationships||Director of Marketing Team||--|
|Tom Megerian M.D., Ph.D.||No Relationships||Executive Director of Clinical Research||--|
EPIX Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Elkan R. Gamzu Ph.D.||49 Relationships||EPIX Pharmaceuticals, Inc.||73|
|Mark W. Leuchtenberger||17 Relationships||NeuroHealing Pharmaceuticals Inc.||59|
|Tamas Bartfai Ph.D.||39 Relationships||The Scripps Research Institute||--|
|Ian F. Smith CPA, ACA||46 Relationships||Vertex Pharmaceuticals Incorporated||50|
|Michael Gilman Ph.D.||82 Relationships||Padlock Therapeutics, Inc.||61|
EPIX Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Compensation Committee||Mark W. Leuchtenberger||17 Relationships||2 Executives|
|Advisory Board Ph.D.||Tamas Bartfai||39 Relationships||8 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
INDUSTRY EXECUTIVE CHANGESThere is no Executive Change data available.
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.